This study investigates the effects of an investigational medication compared to a daily oral dose of another treatment in adults with relapsing forms of multiple sclerosis (RMS). This study aims to measure the annualized relapse rate (ARR) in participants aged 18 to 55 who have been diagnosed with RMS.Participants will …
This study investigates a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) in adults who do not respond to standard treatments. The study will compare the investigational medication with a placebo to assess its safety and effectiveness.Participants will be divided into study arms, receiving either the investigational medication or a placebo. …
This study investigates the effectiveness and safety of an investigational medication compared to intravenous immunoglobulin (IVIg) in adults with chronic inflammatory demyelinating polyneuropathy (CIDP). Participants in this study are adults who are already receiving IVIg but continue to experience physical challenges.The study involves comparing the investigational medication to the usual …
This study investigates the effect of an investigational medication on reducing itchiness in individuals with Lichen Simplex Chronicus (LSC). The purpose of this study is to compare the effectiveness of the investigational medication given by injection to a placebo in adults aged 18 and over who have moderate-to-severe LSC.Participants will …
This study investigates the safety of an investigational pneumococcal vaccine in healthy infants aged approximately 2 months. The purpose is to compare its safety profile to a licensed 20-valent pneumococcal conjugate vaccine. Infants participating in the study will receive either the investigational vaccine or the licensed vaccine as part of …
This study investigates the safety and immune response of an investigational pneumococcal conjugate vaccine, referred to as PCV21, in infants. The purpose is to determine if PCV21 can stimulate the production of antibodies when administered after one, two, or three doses of a licensed 20-valent pneumococcal vaccine. This is compared …
This study investigates the impact of an investigational medication compared to standard care on lung function in adults with uncontrolled moderate to severe asthma. This study aims to determine if the investigational medication can prevent or slow down the decline in lung function.Participants in the study will be randomly assigned …
This study investigates an investigational medication for adults with moderate to severe ulcerative colitis (UC). The purpose of this study is to evaluate the effectiveness and safety of the investigational medication compared to a placebo. Participants will be divided into four study arms, with three different doses of the investigational …
This study investigates the efficacy and safety of an investigational therapy compared to a placebo in adults aged 18 and older with moderately to severely active ulcerative colitis. Participants in this study have an eosinophilic phenotype, meaning they have higher levels of eosinophils, a type of white blood cell, in …
This study investigates the safety and efficacy of an investigational medication for individuals aged 12 and older with moderate to severe atopic dermatitis. The study aims to understand how this medication affects participants over a long-term period.Participants will receive the investigational medication through injections under the skin. This open-label study …
